Cancer related malnutrition is driven by a combined effect of reduced nutritional intake and metabolic changes5-7. These factors contribute to negative energy and protein balance leading to weight and muscle mass loss1.
Poor nutritional status in addition to weight and muscle mass loss can lead to poorer outcomes for the patient. Clinically this impacts not only the patient but also the healthcare setting in a number of ways.
Identification of malnutrition through screening is imperative, as recognised by the National Institute for Health and Care Excellence (NICE)16 and the European Society for Clinical Nutrition and Metabolism (ESPEN).5,17 Screening should be performed at the time of diagnosis.
Benefit of nutritional intervention on several quality of life aspects during treatment.18
Up to 50% reduction in post-operative complications after pre-operative ONS intervention.19,20
Up to a 3-day reduction in length of hospital stay.20
20% increase in probability of survival following early nutritional intervention and weight gain in some cancer patients.21
The causes of reduced nutritional intake are complex and multifactorial.5 Two prevelant causes of malnutrition in oncology patients are taste disturbance and poor appetite:
Taste and smell alterations may develop throughout the course of the disease, before, during and up to one year after treatment.5 Taste alterations could lead to a reduced intake of food and therefore have a negative impact on the nutritional status with up to 25% reduction in nutritional intake, leading to greater weight loss.22,23
The Fortisip Compact Protein range has been developed with a wide range of flavours, providing a flavour variety to your patients can help prevent taste fatigue.24 A high energy, high protein, low volume ONS with specific warming and cooling sensations appreciated in patients with Cancer.* Addressing the needs of taste alterations in cancer through creating sensations could help with compliance.
Low volume ONS may make it easier to consume the energy levels needed25, 26, particularly with reported side effects in oncology patients. Compliance with low volume 125ml ONS is significantly better than standard ONS.25,26
Adapted from Hubbard et al. 201226
Fortisip Compact Protein has been developed, offering a high energy, high protein, low volume ONS with 90% compliance.27
Contact our team of experts for guidance on the use and composition of our product range, for support with queries regarding your Nutricia account and sampling service or to get in touch with your local Nutricia representative. We are available Monday to Thursday 9am-5pm and Friday 9am-4pm (except Bank Holidays)
*de Haan et al. Support Care Cancer. 2021. . https://doi.org/10.1007/s00520-021-06049-4